Information message

In order to see all the search results and access content, you must log in. Please use the Log-in button at the top of the page.

Displaying 13 - 24 of 436
Basic Science
EASL Journal Club: Single-cell atlas of human liver development reveals pathways directing hepatic cell fates

EASL Journal Club: Single-cell atlas of human liver development reveals pathways directing hepatic cell fates

EASL Journal Club
View
Viral Hepatitis
EASL Journal Club: Liver cancer risk after HCV cure in patients with advanced liver disease without non-characterized nodules

EASL Journal Club: Liver cancer risk after HCV cure in patients with advanced liver disease without non-characterized nodules

EASL Journal Club
View
Cirrhosis & Complications
EASL Journal Club: Performance of routine risk scores for predicting cirrhosis-related morbidity in the community

EASL Journal Club: Performance of routine risk scores for predicting cirrhosis-related morbidity in the community

EASL Journal Club
View
General Hepatology
EASL Journal Club: Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation

EASL Journal Club: Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation

EASL Journal Club
View
Metabolism, Alcohol & Toxicity
EASL Journal Club: Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease

EASL Journal Club: Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease

EASL Journal Club
View
Metabolism, Alcohol & Toxicity
EASL Journal Club: Fructose- and sucrose- but not glucose-sweetened beverages promote hepatic de novo lipogenesis: A randomized controlled trial

EASL Journal Club: Fructose- and sucrose- but not glucose-sweetened beverages promote hepatic de novo lipogenesis: A randomize...

EASL Journal Club
View
Metabolism, Alcohol & Toxicity
Quiz: A man of 40 years of age is diagnosed with slightly elevated transaminases

Quiz: A man of 40 years of age is diagnosed with slightly elevated transaminases

Quiz
View

EASL Studio S6 E10: YI Choice: Citizen science: Societal engagement in hepatology

Description

This episode aims at highlighting the importance of patient and public involvement in research. More precisely, the speakers focus on the importance of involving patients in research, practical steps to involve patients in research, and insights from EASL including engagement of patients in the EASL-Lancet Commission.

Faculty

  • Marta Alonso-Peña (Moderator)
  • Kate Jack (Faculty)
  • Marko Korenjak (Faculty)
  • Thomas Marjot (Faculty)

Related episode

ℹ️ Please click here to access the podcast version of this EASL Studio episode.

Log in to post comments
EASL Membership
Off
General Hepatology
EASL Studio Podcast S6 E10: YI Choice: Citizen science: Societal engagement in hepatology

EASL Studio Podcast S6 E10: YI Choice: Citizen science: Societal engagement in hepatology

Podcasts
View
Viral Hepatitis
Quiz: A 45-year-old man who injects drugs is diagnosed with chronic hepatitis C

Quiz: A 45-year-old man who injects drugs is diagnosed with chronic hepatitis C

Quiz
View

EASL Studio S3 E3: Primary biliary cholangitis: A look at the future landscape of therapy for patients

Description

In honour of Primary Biliary Cholangitis (PBC) awareness month, this EASL studio discusses the future therapy-landscape for patients by highlighting:

  • The importance of correctly diagnosing PBC
  • The need of addressing both symptoms and liver disease severity
  • Current and future approaches for treating PBC

Faculty

  • Prof. Gideon Hirschfield (Moderator)
  • Prof. Ana Lleo (Faculty)
  • Dr Femi Adekunle (Faculty, Advanz Pharma representative)
  • Dr Stuart Kendrick (Faculty, GSK representative)
  • Dr Charles A. McWherter (Faculty, CymaBay representative)
  • Dr Claudia Zein (Faculty, Ipsen representative)

ℹ️ Please click here to access the podcast version of this EASL Studio episode.

This EASL Studio is supported by Advanz Pharma, CymaBay, GSK and Ipsen.

 

Log in to post comments
Liver Tumours
EASL Studio Podcast S6 E9: Therapy hierarchy in HCC: A new kid on the block

EASL Studio Podcast S6 E9: Therapy hierarchy in HCC: A new kid on the block

Podcasts
View